• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DNA 甲基转移酶抑制剂的分子建模与虚拟筛选。

Molecular modeling and virtual screening of DNA methyltransferase inhibitors.

机构信息

Torrey Pines Institute for Molecular Studies, 11350 SW Village Parkway, Port St. Lucie, Florida 34987, USA.

出版信息

Curr Pharm Des. 2013;19(12):2138-47. doi: 10.2174/1381612811319120002.

DOI:10.2174/1381612811319120002
PMID:23016844
Abstract

Inhibition of DNA methyltransferases (DNMTs) is a promising approach for the therapeutic treatment of cancer and other diseases. In this work, we review the recent progress on the molecular modeling and virtual screening toward the identification of key structural features associated with the enzyme inhibitory action of active compounds and to identify DNMT inhibitors with novel molecular scaffolds. We discuss the molecular modeling with the co-factor binding site using a recent crystallographic structure of the methyltransferase domain of human DNMT1. We also review the emerging synergy of molecular modeling and chemoinformatic approaches applied to epigenetic therapies targeting DNMTs.

摘要

抑制 DNA 甲基转移酶(DNMTs)是治疗癌症和其他疾病的一种很有前途的方法。在这项工作中,我们回顾了近年来在分子建模和虚拟筛选方面的最新进展,以确定与活性化合物酶抑制作用相关的关键结构特征,并鉴定具有新型分子骨架的 DNMT 抑制剂。我们使用最近获得的人 DNMT1 甲基转移酶结构域的晶体结构讨论了共因子结合位点的分子建模。我们还回顾了分子建模与化学生信学方法在针对 DNMT 的表观遗传学治疗中的协同作用。

相似文献

1
Molecular modeling and virtual screening of DNA methyltransferase inhibitors.DNA 甲基转移酶抑制剂的分子建模与虚拟筛选。
Curr Pharm Des. 2013;19(12):2138-47. doi: 10.2174/1381612811319120002.
2
Inhibitors of DNA methyltransferases: insights from computational studies.DNA 甲基转移酶抑制剂:计算研究的新视角。
Curr Med Chem. 2012;19(21):3475-87. doi: 10.2174/092986712801323289.
3
Towards the chemoinformatic-based identification of DNA methyltransferase inhibitors: 2D- and 3D-similarity profile of screening libraries.迈向基于化学信息学的DNA甲基转移酶抑制剂鉴定:筛选文库的二维和三维相似性概况
Curr Comput Aided Drug Des. 2012 Dec 1;8(4):317-29. doi: 10.2174/157340912803519606.
4
Molecular modeling of inhibitors of human DNA methyltransferase with a crystal structure: discovery of a novel DNMT1 inhibitor.具有晶体结构的人 DNA 甲基转移酶抑制剂的分子建模:新型 DNMT1 抑制剂的发现。
Adv Protein Chem Struct Biol. 2012;87:219-47. doi: 10.1016/B978-0-12-398312-1.00008-1.
5
Targeting DNA methyltransferases for cancer therapy.针对 DNA 甲基转移酶的癌症治疗。
Bioorg Chem. 2024 Oct;151:107652. doi: 10.1016/j.bioorg.2024.107652. Epub 2024 Jul 15.
6
Interaction between DNA/histone methyltransferases and their inhibitors.DNA/组蛋白甲基转移酶与其抑制剂之间的相互作用。
Curr Med Chem. 2015;22(3):360-72. doi: 10.2174/0929867321666141106114538.
7
Molecular modeling studies of the novel inhibitors of DNA methyltransferases SGI-1027 and CBC12: implications for the mechanism of inhibition of DNMTs.新型 DNA 甲基转移酶抑制剂 SGI-1027 和 CBC12 的分子建模研究:对 DNMT 抑制机制的影响。
PLoS One. 2013 Apr 25;8(4):e62152. doi: 10.1371/journal.pone.0062152. Print 2013.
8
DNA methyltransferase inhibitors in cancer: a chemical and therapeutic patent overview and selected clinical studies.DNA 甲基转移酶抑制剂在癌症治疗中的应用:化学和治疗专利概述及部分临床研究
Expert Opin Ther Pat. 2012 Dec;22(12):1427-42. doi: 10.1517/13543776.2012.729579. Epub 2012 Oct 3.
9
Discovery of Reversible DNA Methyltransferase and Lysine Methyltransferase G9a Inhibitors with Antitumoral in Vivo Efficacy.发现具有抗肿瘤体内疗效的可逆 DNA 甲基转移酶和赖氨酸甲基转移酶 G9a 抑制剂。
J Med Chem. 2018 Aug 9;61(15):6518-6545. doi: 10.1021/acs.jmedchem.7b01926. Epub 2018 Jul 19.
10
Effect of Withaferin-A, Withanone, and Caffeic Acid Phenethyl Ester on DNA Methyltransferases: Potential in Epigenetic Cancer Therapy.维甲酰胺-A、醉茄内酯和咖啡酸苯乙酯对 DNA 甲基转移酶的影响:在表观遗传学癌症治疗中的潜力。
Curr Top Med Chem. 2024;24(4):379-391. doi: 10.2174/1568026623666230726105017.

引用本文的文献

1
Short communication: TNF-α and IGF-1 regulates epigenetic mechanisms of HDAC2 and HDAC10.简短通讯:肿瘤坏死因子-α和胰岛素样生长因子-1调节组蛋白去乙酰化酶2和组蛋白去乙酰化酶10的表观遗传机制。
PLoS One. 2022 Feb 10;17(2):e0263190. doi: 10.1371/journal.pone.0263190. eCollection 2022.
2
Identification of protoberberine alkaloids as novel histone methyltransferase G9a inhibitors by structure-based virtual screening.基于结构的虚拟筛选鉴定原小檗碱类化合物为新型组蛋白甲基转移酶 G9a 抑制剂。
J Comput Aided Mol Des. 2018 Sep;32(9):917-928. doi: 10.1007/s10822-018-0156-4. Epub 2018 Aug 31.
3
Specific Inhibition of DNMT3A/ISGF3γ Interaction Increases the Temozolomide Efficiency to Reduce Tumor Growth.
特异性抑制DNMT3A/ISGF3γ相互作用可提高替莫唑胺抑制肿瘤生长的效率。
Theranostics. 2016 Aug 25;6(11):1988-1999. doi: 10.7150/thno.9150. eCollection 2016.
4
Design, synthesis and biological evaluation of 4-amino-N- (4-aminophenyl)benzamide analogues of quinoline-based SGI-1027 as inhibitors of DNA methylation.基于喹啉的SGI-1027的4-氨基-N-(4-氨基苯基)苯甲酰胺类似物作为DNA甲基化抑制剂的设计、合成及生物学评价
ChemMedChem. 2014 Mar;9(3):590-601. doi: 10.1002/cmdc.201300420.
5
Rationalization of activity cliffs of a sulfonamide inhibitor of DNA methyltransferases with induced-fit docking.通过诱导契合对接对DNA甲基转移酶的磺酰胺抑制剂活性悬崖进行合理化分析。
Int J Mol Sci. 2014 Feb 21;15(2):3253-61. doi: 10.3390/ijms15023253.
6
Molecular modeling studies of the novel inhibitors of DNA methyltransferases SGI-1027 and CBC12: implications for the mechanism of inhibition of DNMTs.新型 DNA 甲基转移酶抑制剂 SGI-1027 和 CBC12 的分子建模研究:对 DNMT 抑制机制的影响。
PLoS One. 2013 Apr 25;8(4):e62152. doi: 10.1371/journal.pone.0062152. Print 2013.
7
Docking of a novel DNA methyltransferase inhibitor identified from high-throughput screening: insights to unveil inhibitors in chemical databases.从高通量筛选中鉴定新型 DNA 甲基转移酶抑制剂的对接:揭示化学数据库中抑制剂的见解。
Mol Divers. 2013 May;17(2):337-44. doi: 10.1007/s11030-013-9428-z. Epub 2013 Feb 28.